SAN FRANCISCO – Among the companies whose shares are expected to see active trade in Tuesday's session are Chico's FAS Inc., Advanced Micro Devices Inc., TiVo Inc. and Sycamore Networks Inc.
Chico's FAS Inc. (CHS) is expected to report third-quarter earnings of 28 cents a share, according to analysts polled by Thomson First Call.
Gamestop Corp. (GME) is seen posting earnings of 14 cents a share in its third quarter.
Semtech Corp. (SMTC) is expected to post a per-share profit of 14 cents a share in its third quarter.
SkillSoft PLC's (SKIL) third-quarter profit is expected to come in at 3 cents a share
Sycamore Networks Inc. (SCMR) is seen posting a profit of a penny a share in its fiscal first quarter
TiVo Inc.'s (TIVO) third quarter is expected to show a per-share loss of 24 cents a share.
United Natural Foods Inc. (UNFI) is expected to report fiscal first-quarter earnings of 24 cents a share.
After Monday's closing bell, Advanced Micro Devices Inc. (AMD) said its Spansion memory-chip unit will post a fourth-quarter operating loss, according to a filing with the Securities and Exchange Commission. AMD did not estimate the loss. Through the nine months ended Sept. 25, Spansion has racked up an operating loss of $257 million due to pricing pressure and product delays. Spansion is trying to complete an initial public offering. It aims to sell about 39 million Class A shares in the range of $16 to $18 a share.
Applebee's International Inc. (APPB) said system-wide comparable sales increased 0.7% in November. The Overland Park, Kan.-based restaurant chain said comparable sales for franchise restaurants rose 1.4%, but fell 1.4% for company restaurants.
Bell Microproducts Inc. (BELM) has agreed to acquire MCE, a European distributor of disk drives and components based in Germany. Financial terms weren't disclosed. The acquisition is expected to add to annual earnings by 4 cents to 6 cents a share, San Jose, Calif.-based Bell Microproducts said. The transaction is expected to close by Thursday.
Everest Re Group Ltd. (RE) said losses from Hurricane Wilma could reach $230 million after taxes. The Bermuda-based insurer and reinsurer said this year's hurricane season — including Hurricanes Katrina, Rita and Wilma - will result in a modest after-tax operating loss for Everest Re's full year.
Express Scripts Inc. (ESRX) said it expects 2006 earnings in the range of $3.10 to $3.22 a share, which includes 10 cents a share in stock option expenses. Analysts surveyed by Thomson First Call are currently looking for 2006 earnings of $2.98 a share. Express Scripts is a pharmacy-benefits manager based in St. Louis.
General Motors Corp. (GM) confirmed it has agreed to temporarily forgo the 2006 price reductions on components supplied by Delphi Corp. (DPHIQ) to GM, according to a filing with the Securities and Exchange Commission. GM said it will forgo the reductions, which had been previously agreed upon, while Delphi is in talks with its unions on a new labor contract.
Inter Parfums Inc. (IPAR) forecast 2006 net earnings of $16.9 million, or 83 cents a share, on sales of $301 million. Analysts polled by Thomson First Call currently estimate the company's 2006 earnings to come in at 80 cents a share and for sales to reach $305 million.
Landauer Inc. (LDR) reported fiscal fourth-quarter net earnings of $3.1 million, or 34 cents a share, down 32% from $4.53 million, or 51 cents a share, in the year-ago period. Revenue rose to $19 million from $17.6 million last year. Analysts polled by Thomson First Call had estimated earnings of 49 cents a share on revenue of $19 million. For fiscal year 2006, Landauer expects net income to rise 7% to 9% and for revenue to rise 5% to 6%. The Glenwood, Ill.-based company also raised its quarterly dividend 5.9%, to 45 cents from 42.5 cents a share
MasterCard Inc. shareholders approved a plan that will turn the member-owned entity into a public corporation, the company said.
Valeant Pharmaceuticals International (VRX) has agreed to pay $113.5 million in cash to InterMune Inc. (ITMN) to acquire the U.S. and Canadian rights to the hepatitis C drug Infergen from, the companies said. The deal also includes milestone payments. In addition, Valeant said it will acquire $6.5 million in inventory from InterMune. Brisbane, Calif.-based InterMune also said it plans to continue to advance its hepatitis C virus protease inhibitor program, at least through Phase Ib development, without a development partner, and plans to reduce its annual operating expenses by $50 million. InterMune said it will take restructuring charges related to the operating changes of $6 million to $10 million.
ViroPharma Inc. (VPHM) said it plans to sell 7 million shares of its common stock in a public offering. The Exton, Pa.-based pharmaceutical company plans to use the offering's proceeds for working capital and general corporate purposes, and it may also use a portion for its 6% subordinated convertible notes due March 2007.